These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia. Khan M; Muzzafar T; Kantarjian H; Badar I; Short N; Wang X; Chamoun K; Jain P; DiNardo C; Pemmaraju N; Bose P; Borthakur G; Cortes J; Verstovsek S; Garcia-Manero G; Estrov Z Ann Hematol; 2018 Jul; 97(7):1183-1191. PubMed ID: 29557496 [TBL] [Abstract][Full Text] [Related]
8. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Hwang SM; Kim SM; Nam Y; Kim J; Kim S; Ahn YO; Park Y; Yoon SS; Shin S; Kwon S; Lee DS Leuk Res; 2019 Sep; 84():106190. PubMed ID: 31377458 [TBL] [Abstract][Full Text] [Related]
9. Relapsing/remitting skin involvement in a patient with chronic myelomonocytic leukemia. Paolino G; Rovere-Querini P; Bearzi P; Rizzo N; Mercuri SR Int J Dermatol; 2019 Sep; 58(9):e170-e172. PubMed ID: 31115902 [No Abstract] [Full Text] [Related]
10. Granulocytic sarcoma of the small intestine in a patient with chronic myelomonocytic leukemia. Fukushima M; Ono Y; Imai Y Dig Endosc; 2014 Nov; 26(6):757-8. PubMed ID: 25251682 [No Abstract] [Full Text] [Related]
11. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia. Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evidence for extramedullary blast crisis with t(8;13)(q11;p11) in chronic myelomonocytic leukemia. Rao PH; Cesarman G; Coleman M; Acaron S; Verma RS Acta Haematol; 1992; 88(4):201-3. PubMed ID: 1292310 [TBL] [Abstract][Full Text] [Related]
13. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation. Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830 [TBL] [Abstract][Full Text] [Related]
14. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265 [TBL] [Abstract][Full Text] [Related]
16. Chronic myelomonocytic leukemia with abnormal bone marrow eosinophils. Hyde J; Sun T Arch Pathol Lab Med; 2003 Sep; 127(9):1214-6. PubMed ID: 12946218 [TBL] [Abstract][Full Text] [Related]
17. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases. Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L Am J Hematol; 2016 Feb; 91(2):185-92. PubMed ID: 26509444 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Mathew RA; Bennett JM; Liu JJ; Komrokji RS; Lancet JE; Naghashpour M; Messina JL; List AF; Moscinski LC; Zhang L Leuk Res; 2012 Jan; 36(1):72-80. PubMed ID: 21782240 [TBL] [Abstract][Full Text] [Related]
19. Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study. Wassie EA; Itzykson R; Lasho TL; Kosmider O; Finke CM; Hanson CA; Ketterling RP; Solary E; Tefferi A; Patnaik MM Am J Hematol; 2014 Dec; 89(12):1111-5. PubMed ID: 25195656 [TBL] [Abstract][Full Text] [Related]
20. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia. Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P J Clin Pathol; 2009 Sep; 62(9):798-801. PubMed ID: 19734476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]